Color offers integrated virtual cancer care with early detection, personalized guidance, and ongoing support that improves outcomes and reduces costs.
No named decision-maker yet.
No careers mailbox known
Sep 26
Posted a role Senior Software Engineer, AI Platform
Sep 22
2 roles crossed 45 days open
Sep 19
Cancer Screening Advocate (Temporary Contractor) crossed 45 days open
Sep 17
Posted a role Sales Director, Mid-Market - Central (ND, SD, WI, MN, NE, MO, IA, TN, KY, KS)
11 open
+1 this week
$182k stated pay, 9 roles
Kriya is building durable medicines designed to replace chronic re-treatment with a single administration—therapeutic medicines that can scale to millions.
Brian Furmanski · Executive Officer · decision-maker
Katherine Eade · Executive Officer · decision-maker
Curt Herberts · Executive Officer · decision-maker
Michele Stone · Executive Officer · decision-maker
Careers mailbox is known
Sep 26
Posted 2 roles AI Engineer II / III, Warehouse Manager
Jul 31, 2025
Raised a round Venture round $320.8M · SEC Form D
2 open
+2 this week
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound impact on patients' lives. With an asset-centric and patient-centric approach, Centessa is committed to redefining the way medicines are made. Led by a team of leaders, innovators, and entrepreneurs, Centessa is dedicated to revolutionizing the pharmaceutical industry by bringing together the best minds in science and business. Centessa's pipeline encompasses a range of ongoing clinical trials that focus on developing groundbreaking treatments. They prioritize the expansion of patient access to these innovative therapies through their expanded access policy. Investors are also an integral part of Centessa's vision, providing support and resources to further propel their research and development efforts. With a strong emphasis on privacy and regulatory compliance, Centessa ensures that patients' confidentiality is protected and their personal information is handled with utmost care. If you want to stay updated on the latest news and career opportunities at Centessa, you can follow them on their website and social media platforms. Centessa Pharmaceu
No named decision-maker yet.
No careers mailbox known
Sep 27
Posted a role Medical Science Liaison (MSL) – South East
Sep 25
Posted a role Clinical Trial Manager (Contract)
Sep 23
Closed a role Senior Director, Patient Advocacy
2021
Founded
29 open
+4 this week
$205k stated pay, 28 roles
insitro applies machine learning to human genetic and cellular data for drug discovery. Its laboratory generates large datasets specifically designed to train predictive models. The company targets diseases where patient subgroups are poorly understood.
Mary Rozenman · Executive Officer · decision-maker
Duane Valz · Executive Officer · decision-maker
Daphne Koller · Executive Officer, Director · decision-maker
Vijay Pande · Director
Careers mailbox is known
Sep 22
Hiring 2 new roles, 2 closed in 14 days
Sep 8
New executive insitro Appoints Hideo Makimura as Chief Medical Officer to Lead Its Transition to a Clinical-Stage Company · insitro.com
Jan 12
Acquisition insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design · insitro.com
2025
Team shrank to 210 was 289 · US Form 5500 (plan participants)
2018
Founded
13 open
+1 this week
$225k stated pay, 12 roles
truth B 75 100% stale
Scale without the premium. Introducing VITARI™ Who We Are Our Mission & Vision At Element Biosciences, our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity , and open the world of biology to new possibilities.
No named decision-maker yet.
Careers mailbox is known
Sep 23
5 roles in a day board at 19 · opened in Paris
Sep 22
Posted a role, closed 1 Field Service Engineer - Germany · 2 roles crossed 45 days open
Sep 21
Posted 4 roles Director, Regulatory Affairs, Field Service Engineer - Southeast
Jul 11, 2024
Raised a round Series D $277M · PRNewswire
19 open
+5 this week
$166k stated pay, 15 roles
truth B 75 100% stale
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI Diagnostics.
Amoolya Singh · Executive Officer · decision-maker
Susan Tousi · Executive Officer, Director · decision-maker
Lee-Ann Smith-Freeman · Executive Officer · decision-maker
Douglas Schenkel · Executive Officer · decision-maker
Careers mailbox is known
Sep 18
Hiring 1 new role, 2 closed in 14 days
Apr 27
Board appointment DELFI Diagnostics Appoints Charles Newton to Board of Directors · PRNewswire
Dec 1, 2025
Took on debt financing $34.3M · SEC Form D
Oct 10, 2023
Launched DELFI Diagnostics introduces FirstLook Lung blood test · Medical Device Network
2019
Founded
5 open
$151k stated pay, 5 roles
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Posted a role Senior Software Engineer I, Research Informatics
Sep 25
Senior Software Engineer I, Research Informatics crossed 45 days open
1 open
$178k stated pay, 1 roles
Ngmbio develops life-changing medicines rooted in powerful biology, including NGM120 for hyperemesis gravidarum and cancer cachexia.
Diana Bockus · Executive Officer, Director · decision-maker
Jean-Frederic Viret · Executive Officer · decision-maker
Valerie Pierce · Executive Officer · decision-maker
Daniel Kaplan · Executive Officer · decision-maker
Careers mailbox is known
Feb 4, 2025
New executive NGM Bio Announces Appointment of Wendy Yeh, M.D. as Chief Medical Officer · The Manila Times
Jul 5, 2024
Raised a round Venture round $142M · SEC Form D
2024
Founded
NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech integration.
No named decision-maker yet.
Careers mailbox is known
Pioneering a World Free from Complement Disease. The complement system is complex and implicated in a large number of autoimmune and inflammatory conditions across hematology, nephrology, neurology, dermatology, ophthalmology and many other disease areas.
No named decision-maker yet.
Careers mailbox is known
The best way to extend life span is to catch disease early. At identifeye HEALTH we are adding a new dimension to medicine and radically rethinking the processes of healthcare delivery.
No named decision-maker yet.
No careers mailbox known
Sep 27
Moved to Greenhouse
At GoodLab, we help biotech brands stand out with bold storytelling, smart design, and strategic thinking. Let’s build something great together.
No named decision-maker yet.
No careers mailbox known
Learn about Lyell and how we are building an industry-leading clinical-stage pipeline of CAR-T cell product candidates for cancer.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Posted 8 roles Director, Clinical Science, Director or Senior Director, Investor Relations and Corporate Communications
8 open
$241k stated pay, 8 roles
With our opti-ox™ technology, we precisely, consistently, & efficiently reprogram stem cells into any cell type at scale for your research needs. Learn more!
No named decision-maker yet.
Careers mailbox is known
Jan 27, 2025
Launched bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New Visualisation Functionality to Human iPSC-derived Cell Types · PRNewswire
2016
Founded
Access telehealth consultations for urgent needs and ongoing primary care. Talk to a licensed doctor anytime, anywhere with Galileo.
No named decision-maker yet.
Careers mailbox is known
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline. See how.
No named decision-maker yet.
No careers mailbox known
We are using a precision approach to develop therapies designed to transform the lives of patients with immune-mediated diseases.
June Lee · Executive Officer, Director · decision-maker
Roy Hardiman · Executive Officer · decision-maker
Jorn Drappa · Executive Officer · decision-maker
David Goldstein · Executive Officer · decision-maker
Careers mailbox is known
Sep 21
Hiring 1 new role, 3 closed in 14 days
Jul 17, 2024
Raised a round Venture round $40M · SEC Form D
2021
Founded
4 open
$160k stated pay, 3 roles
truth B 75 100% stale
A clinical-stage therapeutics company, Indomo pairs proven medicines with novel delivery systems to create fast-acting, self-administered treatments for inflammatory skin conditions. Its debut investigational product, the ClearPen, combines an established, trusted therapeutic with a novel microneedle device for at-home acne treatment.
No named decision-maker yet.
Careers mailbox is known
2021
Founded
On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of care for autoimmune diseases.
No named decision-maker yet.
Careers mailbox is known
Sep 19
Closed a role Director, Clinical Operations
Sep 18
Posted a role Director, Business Development
Sep 16
Posted a role Accounts Payable & Finance Operations Specialist
2024
Founded
6 open
$203k stated pay, 5 roles
MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. As a leader in polygenic modeling, MyOme leverages the power of the whole genome for a lifetime of actionable insights.
No named decision-maker yet.
Careers mailbox is known
Sep 20
Expired 1 roles
Mar 12
Launched MyOme Debuts Zenith Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 · morningstar.com
